State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
Department of Musculoskeletal Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
Cancer Res. 2024 Apr 1;84(7):994-1012. doi: 10.1158/0008-5472.CAN-23-1307.
Cooperation between primary malignant cells and stromal cells can mediate the establishment of lung metastatic niches. Here, we characterized the landscape of cell populations in the tumor microenvironment in treatment-naïve osteosarcoma using single-cell RNA sequencing and identified a stem cell-like cluster with tumor cell-initiating properties and prometastatic traits. CXCL14 was specifically enriched in the stem cell-like cluster and was also significantly upregulated in lung metastases compared with primary tumors. CXCL14 induced stromal reprogramming and evoked a malignant phenotype in fibroblasts to form a supportive lung metastatic niche. Binding of CXCL14 to heterodimeric integrin α11β1 on fibroblasts activated actomyosin contractility and matrix remodeling properties. CXCL14-stimulated fibroblasts produced TGFβ and increased osteosarcoma invasion and migration. mAbs targeting the CXCL14-integrin α11β1 axis inhibited fibroblast TGFβ production, enhanced CD8+ T cell-mediated antitumor immunity, and suppressed osteosarcoma lung metastasis. Taken together, these findings identify cross-talk between osteosarcoma cells and fibroblasts that promotes metastasis and demonstrate that targeting the CXCL14-integrin α11β1 axis is a potential strategy to inhibit osteosarcoma lung metastasis.
Cooperation between stem-like osteosarcoma cells and fibroblasts mediated by a CXCL14-integrin α11β1 axis creates a tumor-supportive lung metastatic niche and represents a therapeutic target to suppress osteosarcoma metastasis.
原发恶性细胞与基质细胞的合作可以介导肺转移灶的建立。在这里,我们使用单细胞 RNA 测序对未经治疗的骨肉瘤肿瘤微环境中的细胞群体进行了特征描述,并鉴定出一个具有肿瘤起始特性和促转移特性的干细胞样簇。CXCL14 特异性富集在干细胞样簇中,并且与原发性肿瘤相比,在肺转移中也明显上调。CXCL14 诱导基质重编程,并在成纤维细胞中诱发恶性表型,形成支持性肺转移灶。CXCL14 与成纤维细胞上的异二聚体整合素 α11β1 结合,激活肌动球蛋白收缩和基质重塑特性。CXCL14 刺激的成纤维细胞产生 TGFβ,并增加骨肉瘤的侵袭和迁移。针对 CXCL14-整合素 α11β1 轴的 mAb 抑制成纤维细胞 TGFβ 的产生,增强 CD8+T 细胞介导的抗肿瘤免疫,并抑制骨肉瘤肺转移。总之,这些发现确定了骨肉瘤细胞与成纤维细胞之间的相互作用,促进了转移,并表明靶向 CXCL14-整合素 α11β1 轴是抑制骨肉瘤肺转移的潜在策略。
由 CXCL14-整合素 α11β1 轴介导的干细胞样骨肉瘤细胞和成纤维细胞之间的合作,形成了一个支持肿瘤的肺转移灶微环境,代表了抑制骨肉瘤转移的治疗靶点。